We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cello Health Plc | LSE:CLL | London | Ordinary Share | GB00B0310763 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 161.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCLL
RNS Number : 3045R
Cello Group plc
20 September 2017
20 September 2017
Cello Group plc
("Cello" or "the Company")
Additional Block Listing of Ordinary Shares
The Company announces that an application has been made to the London Stock Exchange for a block admission for 1,252,829 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.
These new Ordinary Shares will be issued and allotted from time to time pursuant to the exercise of existing options under the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010. New Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company.
Admission of the new Ordinary Shares is expected to occur on 26 September 2017.
Enquiries:
Cello Group 020 7812 8460 Mark Scott, Chief Executive Mark Bentley, Finance Director Cenkos Securities 0207 397 8900 Bobbie Hilliam Harry Hargreaves
This information is provided by RNS
The company news service from the London Stock Exchange
END
ALSPGUUABUPMGUU
(END) Dow Jones Newswires
September 20, 2017 06:52 ET (10:52 GMT)
1 Year Cello Health Chart |
1 Month Cello Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
